Conformis, Inc. (CFMS): Price and Financial Metrics

Conformis, Inc. (CFMS): $0.86

0.05 (+6.12%)

POWR Rating

Component Grades













CFMS Stock Summary

  • Conformis Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 94.06% of US listed stocks.
  • CFMS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 80.55% of US stocks.
  • Conformis Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -16.06%, greater than the shareholder yield of only 14.56% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Conformis Inc, a group of peers worth examining would be NSPR, SHSP, ATRI, BRKS, and AUTO.
  • CFMS's SEC filings can be seen here. And to visit Conformis Inc's official web site, go to

CFMS Stock Price Chart Interactive Chart >

Price chart for CFMS

CFMS Price/Volume Stats

Current price $0.86 52-week high $1.49
Prev. close $0.81 52-week low $0.60
Day low $0.81 Volume 1,714,608
Day high $0.89 Avg. volume 5,221,760
50-day MA $1.01 Dividend yield N/A
200-day MA $0.84 Market Cap 156.89M

Conformis, Inc. (CFMS) Company Bio

ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient's unique anatomy. The company was founded in 2004 and is based in Bedford, Massachusetts.

CFMS Latest News Stream

Event/Time News Detail
Loading, please wait...

CFMS Latest Social Stream

Loading social stream, please wait...

View Full CFMS Social Stream

Latest CFMS News From Around the Web

Below are the latest news stories about Conformis Inc that investors may wish to consider to help them evaluate CFMS as an investment opportunity.

Conformis Announces License Agreement with Paragon 28

Commercial Interest in Accurate, Disposable, Patient-Specific Instrumentation Continues to ExpandBILLERICA, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a non-exclusive license under a subset of Conformis’ U.S. patents for the use of patient-specific instruments with off-the-shelf implants in Paragon 28’s APEX 3D™ Total Ankle Replacement System. “We are pleased to reach this agreement with Paragon 28, enabling it to incorporate our patient-specific instrument technology in its anticipated total ankle replacement offering,” said Mark Augusti, President and Chief Executive Officer. “We believe that this latest license agreement further demonstrates the broad a...

Yahoo | April 19, 2021

STERIS (STE) Hits a New 52-Week High: What's Driving It?

Investors are optimistic about STERIS (STE) backed by elevated consumer demand and strong segmental growth in third-quarter fiscal 2021.

Yahoo | April 19, 2021

Globus Medical (GMED) Simplifies Spine Surgery With CREO ONE

Globus Medical's (GMED) latest development to robotically navigated spine surgery will enable surgeons to maintain the navigational accuracy without performing traditional pedicle preparation.

Yahoo | April 16, 2021

Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021

BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the market closes on May 5, 2021 at approximately 4:00 p.m. Eastern Time. Mark Augusti, CEO, and Bob Howe, CFO, will host a webcast and conference call also on Wednesday, May 5, 2021, at 4:30 p.m. Eastern Time to discuss the financial results and to provide a business update. The webcast will be live at: To attend by telephone, please use the information below for dial-in access. When prompted on dial-in, please utilize conference ID: 8727027.Participant conference numbers (877) 809-6331 (U.S./Canada) and (615) 247-0224 (International).Please dial in at...

Yahoo | April 7, 2021

Varian Medical (VAR) Hits 52-Week High: What's Driving It?

Varian Medical (VAR) is optimistic about its prospective acquisitions and strength in Proton Therapy segment.

Yahoo | March 26, 2021

Read More 'CFMS' Stories Here

CFMS Price Returns

1-mo -20.37%
3-mo -38.57%
6-mo 16.06%
1-year 26.47%
3-year -45.57%
5-year -93.15%
YTD 30.30%
2020 -56.00%
2019 316.67%
2018 -84.87%
2017 -70.62%
2016 -53.15%

Continue Researching CFMS

Here are a few links from around the web to help you further your research on Conformis Inc's stock as an investment opportunity:

Conformis Inc (CFMS) Stock Price | Nasdaq
Conformis Inc (CFMS) Stock Quote, History and News - Yahoo Finance
Conformis Inc (CFMS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9889 seconds.